ADPT - Adaptive Biotechnologies Corporation
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$21.25
DETAILS
HIGH:
$22.00
LOW:
$21.00
MEDIAN:
$21.00
CONSENSUS:
$21.25
UPSIDE:
53.10%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 74.2% |
| EBIT Margin | -17.2% |
| EBITDA Margin | -10.8% |
| Operating Margin | -20.6% |
| Pretax Margin | -21.5% |
| Cont. Ops Margin | -21.5% |
| Net Margin | -21.5% |
| Bottom Line Margin | -21.5% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 3.34 |
| Quick Ratio | 3.23 |
| Solvency Ratio | -0.145 |
| Cash Ratio | 0.78 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-41.41
Peers avg: 28.7
|
| PEG Ratio | 0.65 |
| Forward PEG | 0.65 |
| Price/Book | 11.26 |
| Price/Sales | 8.90 |
| Price/FCF | -50.34 |
| Price/Op Cash Flow | -53.58 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.5472 |
| Debt/Equity | 1.2824 |
| Debt/Capital | 0.5619 |
| Long-Term Debt/Capital | 0.4735 |
| Financial Leverage | 2.34 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 1.40 |
| Operating Cash Flow Ratio | -0.511 |
| Operating Cash Flow/Sales | -16.6% |
| Free Cash Flow/Operating Cash Flow | 106.4% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -1.18 |
| Interest Coverage | -4.8500 |
| Short-Term Operating Cash Flow Coverage | -3.39 |
| Operating Cash Flow Coverage | -0.16 |
| Capital Expenditure Coverage | -15.54 |
| Dividend + Capital Expenditure Coverage | -15.54 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 1.83 |
| EPS | -0.392 |
| Debt/Share | 1.9270 |
| Cash/Share | 1.50 |
| Book Value/Share | 1.48 |
| Tangible BV/Share | 0.69 |
| Equity/Share | 1.44 |
| Operating Cash Flow/Share | -0.303 |
| Capital Expenditure/Share | 0.020 |
| FCF/Share | -0.323 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.001 |
| Earnings Before Tax/EBIT | 1.041 |
| Price/Fair Value | 11.26 |
| Debt/Market Cap | 0.0854 |
| Effective Tax Rate | 0.0% |
| Enterprise Value Multiple | -89.60 |